We are working to bring down the price of antiretroviral drugs so that people living with HIV, in middle-income countries, have access to treatment.
Who we are
We are a coalition of organizations working together to make essential HIV medicines more affordable to the people who need them.
This website represents the work of two major initiatives. The first is a consortium of partners led by the International Treatment Preparedness Coalition, and including legal experts Initiative for Medicines, Access & Knowledge and four national partners: Fundación Grupo Efecto Positivo in Argentina; Associação Brasileira Interdisciplinar de AIDS in Brazil; AIDS Access Foundation in Thailand; and All-Ukrainian Network of People Living with HIV in Ukraine. The joint program is called ‘Making HIV treatment affordable in middle income countries’ and is funded by UNITAID.
The other initiative, funded by Aids Fonds, brings together nine regional and national organizations that are working on similar strategies to reduce the price of antiretroviral drugs.
What we do
Make antiretroviral drugs more affordable
To make antiretroviral drugs more affordable, our strategy is to remove barriers to market competition amongst drug manufacturers. We promote healthy competition by supporting governments to issue selective compulsory licenses, whereby they allow others to produce the patented product without the consent of the patent owner. We also challenge undeserved patents. Find out more about our strategies.
The savings could be as much as US$150 million a year in our original four focus countries. These savings could be used to treat an additional 130,000 patients in these countries.
Influence markets in neighboring countries
We also aim to influence markets in other countries by sharing knowledge with community and civil society organizations. By communicating the outcomes of our work, we hope to inspire activists to replicate actions and achieve similar results elsewhere.